{"name":"OxThera","slug":"oxthera","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oxabact OC5 - Oxalobacter formigenes HC-1","genericName":"Oxabact OC5 - Oxalobacter formigenes HC-1","slug":"oxabact-oc5-oxalobacter-formigenes-hc-1","indication":"Primary Hyperoxaluria Type 1 (PH1)","status":"phase_3"}]}],"pipeline":[{"name":"Oxabact OC5 - Oxalobacter formigenes HC-1","genericName":"Oxabact OC5 - Oxalobacter formigenes HC-1","slug":"oxabact-oc5-oxalobacter-formigenes-hc-1","phase":"phase_3","mechanism":"Oxabact OC5 is a live biotherapeutic product that works by colonizing the gut with Oxalobacter formigenes HC-1, which degrades oxalate, reducing its absorption and systemic levels.","indications":["Primary Hyperoxaluria Type 1 (PH1)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1DcmVKeEJGQnlCMmhud3VuSlo2bGZ3QWhrcnNxbU1EU3EyemFKT0xjZ3JvYU1TNTJkWERheTdWcWQ2SmozRXZkTUNmcjB0NURYcTNLeko1aW05Zzh0SVEweFF0bTlrYWpHQ1IzTVpHS3RDYzMxSUV6WA?oc=5","date":"2022-06-23","type":"pipeline","source":"Labiotech.eu","summary":"Meet the Swedish Biotech that is Set to Cure a Rare Kidney Disease - Labiotech.eu","headline":"Meet the Swedish Biotech that is Set to Cure a Rare Kidney Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOYnhNdktqMi14ZWVlY0ZOcGJ4YWdpVW56SHRfUmdYR3hPbm1FUTJnSERBU1U0TG9iSkhWUzRjMjBGZ0xSLXFPMHBqUTlEdEw3bV96ZEVRNUZfNlpZZkpVNWJNck15VGpLQ2E1MzRqTFRRTGJhbzdiWE45WUdpS2RuaUJ2RHJ3RG5WMUgtQjh2Q1JDLTdfajdnS250b2FTb1d4Z0xZeENvdWVHdkduZ2Y0?oc=5","date":"2021-04-20","type":"pipeline","source":"The Business Journals","summary":"Castle Creek Biosciences names new CEO - The Business Journals","headline":"Castle Creek Biosciences names new CEO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}